Help

Biopure, a biopharmaceutical company started in 1984, specializes in the purification of animal and human proteins. Among other products, the company has been generating two forms of blood substitutes: one for human, and another for animals. These substitutes are designed as an alternative to the use of fresh blood in transfusions. Using a blood base derived from cattle, the company purifies the blood of foreign antigens and modifies the hemoglobin proteins in the blood to improve the shelf life and improve the acceptability to the recipient. Unlike the human blood substitutes offered by its two main competitors Baxter International and Northfield Laboratories, Biopure’s Hemopure and Oxyglobin product lines can be stored without refrigeration.
Biopure was faced with the problem of devising methods of preventing its two products from indirectly and adversely affecting each other in the market, as well as compete actively and effectively with its two competitors in the hum...